Itaconix Plc engages in designing, developing, and formulating novel polymers to improve the performance of existing consumer products. The company is headquartered in Stratham, New Hampshire and currently employs 22 full-time employees. The company went IPO on 2012-07-10. The Company’s principal activities are the development of plant-based polymers, and the production and sale of these materials globally, both directly and through partners as ingredients in product formulations. The Company’s segments include Itaconix Performance Ingredients, SPARX Formulated Solutions, and BIO*Asterix. Itaconix Performance Ingredients develops, produces, and sells proprietary specialty polymers that are used as functional ingredients to meet customer needs in cleaning, beauty and hygiene products. SPARX Formulated Solutions provides technical services and ingredient supplies for formulated products developed for customers based on Performance Ingredients. BIO*Asterix develops, produces, and sells specialty itaconate monomers as plant-based alternatives to acrylates and styrenes in paint, coating, and adhesive applications.
Mr. John Shaw est le Chief Executive Officer de Itaconix plc, il a rejoint l'entreprise depuis 2018.
Quelle est la performance du prix de l'action ITACONIX PLC ?
Le prix actuel de ITACONIX PLC est de $1.2, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Itaconix plc ?
Itaconix plc appartient à l'industrie Chemicals et le secteur est Materials
Quel est la capitalisation boursière de Itaconix plc ?
La capitalisation boursière actuelle de Itaconix plc est de $16.1M
Est-ce que Itaconix plc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 3 analystes ont établi des notations d'analystes pour Itaconix plc, y compris 3 achat fort, 5 achat, 1 maintien, 0 vente et 3 vente forte